Nomura Asset Management CO LTD Cytom X Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$9.35 - $11.41 $0 - $0
0 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$9.5 - $19.16 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019
BUY
$9.5 - $19.16 $0 - $0
0 New
0 $0
Q4 2018

Feb 12, 2019
BUY
$12.69 - $18.61 $0 - $0
0 New
0 $0
Q3 2018

Nov 07, 2018
BUY
$18.04 - $26.41 $0 - $0
0 New
0 $0
Q2 2018

Aug 03, 2018
BUY
$21.38 - $29.68 $0 - $0
0 New
0 $0
Q1 2018

May 14, 2018
BUY
$21.76 - $34.22 $0 - $0
0 New
0 $0
Q4 2017

Feb 14, 2018
BUY
$19.0 - $23.09 $0 - $0
0
0 $0

Others Institutions Holding CTMX

# of Institutions
72
Shares Held
49.4M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $55.4M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email